BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fiore A, Liang Y, Lin YH, Tung J, Wang H, Langlais D, Nijnik A. Deubiquitinase MYSM1 in the Hematopoietic System and beyond: A Current Review. Int J Mol Sci 2020;21:E3007. [PMID: 32344625 DOI: 10.3390/ijms21083007] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 5.5] [Reference Citation Analysis]
Number Citing Articles
1 Bleesing J. Gain-of-function defects in toll-like receptor 8 shed light on the interface between immune system and bone marrow failure disorders. Front Immunol 2022;13:935321. [DOI: 10.3389/fimmu.2022.935321] [Reference Citation Analysis]
2 Pan X, Wu S, Wei W, Chen Z, Wu Y, Gong K. Structural and Functional Basis of JAMM Deubiquitinating Enzymes in Disease. Biomolecules 2022;12:910. [DOI: 10.3390/biom12070910] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Zhao J, Jia Y, Mahmut D, Deik AA, Jeanfavre S, Clish CB, Sankaran VG. Human hematopoietic stem cell vulnerability to ferroptosis.. [DOI: 10.1101/2022.06.03.494357] [Reference Citation Analysis]
4 Liu X, Liu X, Cai M, Luo A, He Y, Liu S, Zhang X, Yang X, Xu L, Jiang H. CircRNF220, not its linear cognate gene RNF220, regulates cell growth and is associated with relapse in pediatric acute myeloid leukemia. Mol Cancer 2021;20:139. [PMID: 34702297 DOI: 10.1186/s12943-021-01395-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
5 Al-doory SA, Abdalqader AM, Mir FF, Saleh SM, Radaideh MA, Al Sabbah MA. A Rare Cause of Bone Marrow Failure Syndrome and Immunodeficiency. Dubai Med J. [DOI: 10.1159/000519579] [Reference Citation Analysis]
6 Guo D, Zhou Y, Wei X, Zhang S, Jin T, Zhang Y, Lin M, Zhou X, Xie Y, He C, Lin Q, He P, Ding Y. Preliminary study of genome-wide association identifies novel susceptibility genes for serum mineral elements in the Chinese Han population. Biol Trace Elem Res 2021. [PMID: 34417961 DOI: 10.1007/s12011-021-02854-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Barabino SML, Citterio E, Ronchi AE. Transcription Factors, R-Loops and Deubiquitinating Enzymes: Emerging Targets in Myelodysplastic Syndromes and Acute Myeloid Leukemia. Cancers (Basel) 2021;13:3753. [PMID: 34359655 DOI: 10.3390/cancers13153753] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Barhoom D, Mohseni R, Behfar M, Hamidieh AA. Successful allogeneic stem cell transplantation with fludarabine-based reduced intensity conditioning in bone marrow failure syndrome 4. Pediatr Transplant 2021;:e14089. [PMID: 34302415 DOI: 10.1111/petr.14089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
9 Hariri H, St-Arnaud R. Expression and Role of Ubiquitin-Specific Peptidases in Osteoblasts. Int J Mol Sci 2021;22:7746. [PMID: 34299363 DOI: 10.3390/ijms22147746] [Reference Citation Analysis]
10 Lin YH, Wang H, Fiore A, Förster M, Tung LT, Belle JI, Robert F, Pelletier J, Langlais D, Nijnik A. Loss of MYSM1 inhibits the oncogenic activity of cMYC in B cell lymphoma. J Cell Mol Med 2021;25:7089-94. [PMID: 34114734 DOI: 10.1111/jcmm.16554] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
11 Huang J, Zhan XY, Zhao AL, Wu B, Yang Y, Tan P, Wan LJ, Lu YH. [A novel compound heterozygous mutation in MYSM1 gene in a 1-month-old girl: a bone marrow failure syndrome 4 family survey and literature review]. Zhonghua Xue Ye Xue Za Zhi 2021;42:129-34. [PMID: 33858043 DOI: 10.3760/cma.j.issn.0253-2727.2021.02.007] [Reference Citation Analysis]
12 Budroni V, Versteeg GA. Negative Regulation of the Innate Immune Response through Proteasomal Degradation and Deubiquitination. Viruses 2021;13:584. [PMID: 33808506 DOI: 10.3390/v13040584] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
13 Belle JI, Wang H, Fiore A, Petrov JC, Lin YH, Feng CH, Nguyen TTM, Tung J, Campeau PM, Behrends U, Brunet T, Leszinski GS, Gros P, Langlais D, Nijnik A. MYSM1 maintains ribosomal protein gene expression in hematopoietic stem cells to prevent hematopoietic dysfunction. JCI Insight 2020;5:125690. [PMID: 32641579 DOI: 10.1172/jci.insight.125690] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]